[en] Chemokines regulate directed cell migration, proliferation and survival and are key components in cancer biology. They exert their functions by interacting with seven-transmembrane domain receptors that signal through G proteins (GPCRs). A subgroup of four chemokine receptors known as the atypical chemokine receptors (ACKRs) has emerged as essential regulators of the chemokine functions. ACKRs play diverse and complex roles in tumor biology from tumor initiation to metastasis, including cancer cell proliferation, adherence to endothelium, epithelial-mesenchymal transition (EMT), extravasation from blood vessels, tumor-associated angiogenesis or protection from immunological responses. This chapter gives an overview on the established and emerging roles that the atypical chemokine receptors ACKR1, ACKR2, ACKR3 and ACKR4 play in the different phases of cancer development and dissemination, their clinical relevance, as well as on the hurdles to overcome in ACKRs targeting as cancer therapy.
Abe, P., Mueller, W., Schutz, D., MacKay, F., Thelen, M., Zhang, P., CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons (2014) Development, 141 (9), pp. 1857-1863
Addison, C.L., Belperio, J.A., Burdick, M.D., Strieter, R.M., Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis (2004) BMC Cancer, 4, p. 28
Adlere, I., Caspar, B., Arimont, M., Dekkers, S., Visser, K., Stuijt, J., Modulators of CXCR4 and CXCR7/ACKR3 function (2019) Molecular Pharmacology
Ameti, R., Melgrati, S., Radice, E., Cameroni, E., Hub, E., Thelen, S., Characterization of a chimeric chemokine as a specific ligand for ACKR3 (2018) Journal of Leukocyte Biology, 104 (2), pp. 391-400
Bachelerie, F., Ben-Baruch, A., Burkhardt, A.M., Combadiere, C., Farber, J.M., Graham, G.J., International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors (2014) Pharmacological Reviews, 66 (1), pp. 1-79
Bachelerie, F., Graham, G.J., Locati, M., Mantovani, A., Murphy, P.M., Nibbs, R., New nomenclature for atypical chemokine receptors (2014) Nature Immunology, 15 (3), pp. 207-208
Bachelerie, F., Graham, G.J., Locati, M., Mantovani, A., Murphy, P.M., Nibbs, R., An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15 (2015) British Journal of Pharmacology, 172 (16), pp. 3945-3949
Balabanian, K., Lagane, B., Infantino, S., Chow, K.Y., Harriague, J., Moepps, B., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes (2005) The Journal of Biological Chemistry, 280 (42), pp. 35760-35766
Bandyopadhyay, S., Zhan, R., Chaudhuri, A., Watabe, M., Pai, S.K., Hirota, S., Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression (2006) Nature Medicine, 12 (8), pp. 933-938
Becker, J.H., Gao, Y., Soucheray, M., Pulido, I., Kikuchi, E., Rodriguez, M.L., CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC (2019) Cancer Research, 79 (17), pp. 4439-4452
Behnam Azad, B., Lisok, A., Chatterjee, S., Poirier, J.T., Pullambhatla, M., Luker, G.D., Targeted imaging of the atypical chemokine receptor 3 (ACKR3/CXCR7) in human cancer xenografts (2016) Journal of Nuclear Medicine, 57 (6), pp. 981-988
Benhadjeba, S., Edjekouane, L., Sauve, K., Carmona, E., Tremblay, A., Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor alpha in ovarian cancer (2018) Molecular Oncology, 12 (10), pp. 1689-1705
Berahovich, R.D., Zabel, B.A., Lewen, S., Walters, M.J., Ebsworth, K., Wang, Y., Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels (2014) Immunology, 141 (1), pp. 111-122
Berahovich, R.D., Zabel, B.A., Penfold, M.E., Lewen, S., Wang, Y., Miao, Z., CXCR7 protein is not expressed on human or mouse leukocytes (2010) Journal of Immunology, 185 (9), pp. 5130-5139
Bianco, A.M., Uno, M., Oba-Shinjo, S.M., Clara, C.A., de Almeida Galatro, T.F., Rosemberg, S., CXCR7 and CXCR4 expressions in infiltrative astrocytomas and their interactions with HIF1alpha expression and IDH1 mutation (2015) Pathology Oncology Research, 21 (2), pp. 229-240
Birner, P., Tchorbanov, A., Natchev, S., Tuettenberg, J., Guentchev, M., The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner (2015) Journal of Clinical Pathology, 68 (10), pp. 830-834
Boehm, M., Beaumont, K., Jones, R., Kalgutkar, A.S., Zhang, L., Atkinson, K., Discovery of potent and orally bioavailable macrocyclic peptide-peptoid hybrid CXCR7 modulators (2017) Journal of Medicinal Chemistry, 60 (23), pp. 9653-9663
Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Control of chemokine-guided cell migration by ligand sequestration (2008) Cell, 132 (3), pp. 463-473
Bonecchi, R., Locati, M., Galliera, E., Vulcano, M., Sironi, M., Fra, A.M., Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor (2004) Journal of Immunology, 172 (8), pp. 4972-4976
Bonini, J.A., Martin, S.K., Dralyuk, F., Roe, M.W., Philipson, L.H., Steiner, D.F., Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3 (1997) DNA and Cell Biology, 16 (10), pp. 1249-1256
Borroni, E.M., Cancellieri, C., Vacchini, A., Benureau, Y., Lagane, B., Bachelerie, F., Beta-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6 (2013) Science Signaling, 6 (273), pp. S31-S33. , ra30 31–11
Bunting, M.D., Comerford, I., Seach, N., Hammett, M.V., Asquith, D.L., Korner, H., CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity (2013) Blood, 121 (1), pp. 118-128
Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells (2005) Blood, 106 (5), pp. 1824-1830
Burns, J.M., Summers, B.C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development (2006) The Journal of Experimental Medicine, 203 (9), pp. 2201-2213
Calatozzolo, C., Canazza, A., Pollo, B., Di Pierro, E., Ciusani, E., Maderna, E., Expression of the new CXCL12 receptor, CXCR7, in gliomas (2011) Cancer Biology & Therapy, 11 (2), pp. 242-253
Canals, M., Scholten, D.J., de Munnik, S., Han, M.K., Smit, M.J., Leurs, R., Ubiquitination of CXCR7 controls receptor trafficking (2012) PLoS One, 7 (3)
Catusse, J., Leick, M., Groch, M., Clark, D.J., Buchner, M.V., Zirlik, K., Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia (2010) Molecular Cancer, 9, p. 297
Chakera, A., Seeber, R.M., John, A.E., Eidne, K.A., Greaves, D.R., The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization (2008) Molecular Pharmacology, 73 (5), pp. 1362-1370
Chaudhuri, A., Nielsen, S., Elkjaer, M.L., Zbrzezna, V., Fang, F., Pogo, A.O., Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs (1997) Blood, 89 (2), pp. 701-712
Chaudhuri, A., Zbrzezna, V., Polyakova, J., Pogo, A.O., Hesselgesser, J., Horuk, R., Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor (1994) The Journal of Biological Chemistry, 269 (11), pp. 7835-7838
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3 (2011) Cancer Cell, 19 (4), pp. 541-555
Chevigne, A., Fievez, V., Schmit, J.C., Deroo, S., Engineering and screening the N-terminus of chemokines for drug discovery (2011) Biochemical Pharmacology, 82 (10), pp. 1438-1456
Coggins, N.L., Trakimas, D., Chang, S.L., Ehrlich, A., Ray, P., Luker, K.E., CXCR7 controls competition for recruitment of beta-arrestin 2 in cells expressing both CXCR4 and CXCR7 (2014) PLoS One, 9 (6)
Comerford, I., Milasta, S., Morrow, V., Milligan, G., Nibbs, R., The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro (2006) European Journal of Immunology, 36 (7), pp. 1904-1916
Comerford, I., Nibbs, R.J., Litchfield, W., Bunting, M., Harata-Lee, Y., Haylock-Jacobs, S., The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses (2010) Blood, 116 (20), pp. 4130-4140
Cutbush, M., Mollison, P.L., Parkin, D.M., A new human blood group (1950) Nature, 165 (4188), pp. 188-189
D'Alterio, C., Consales, C., Polimeno, M., Franco, R., Cindolo, L., Portella, L., Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer (2010) Current Cancer Drug Targets, 10 (7), pp. 772-781
Darbonne, W.C., Rice, G.C., Mohler, M.A., Apple, T., Hebert, C.A., Valente, A.J., Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin (1991) The Journal of Clinical Investigation, 88 (4), pp. 1362-1369
Datar, I., Sanmamed, M.F., Wang, J., Henick, B.S., Choi, J., Badri, T., Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis (2019) Clinical Cancer Research, 25 (15), pp. 4663-4673
Dawson, T.C., Lentsch, A.B., Wang, Z., Cowhig, J.E., Rot, A., Maeda, N., Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC) (2000) Blood, 96 (5), pp. 1681-1684
Dona, E., Barry, J.D., Valentin, G., Quirin, C., Khmelinskii, A., Kunze, A., Directional tissue migration through a self-generated chemokine gradient (2013) Nature, 503 (7475), pp. 285-289
Donzella, G.A., Schols, D., Lin, S.W., Este, J.A., Nagashima, K.A., Maddon, P.J., AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor (1998) Nature Medicine, 4 (1), pp. 72-77
Dorf, M.E., Berman, M.A., Tanabe, S., Heesen, M., Luo, Y., Astrocytes express functional chemokine receptors (2000) Journal of Neuroimmunology, 111 (1-2), pp. 109-121
Du, J., Luan, J., Liu, H., Daniel, T.O., Peiper, S., Chen, T.S., Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress (2002) Journal of Leukocyte Biology, 71 (1), pp. 141-153
Elson, J.K., Beebe-Dimmer, J.L., Morgenstern, H., Chilkuri, M., Blanchard, J., Lentsch, A.B., The Duffy antigen/receptor for chemokines (DARC) and prostate-cancer risk among Jamaican men (2011) Journal of Immigrant and Minority Health, 13 (1), pp. 36-41
Feng, L.Y., Ou, Z.L., Wu, F.Y., Shen, Z.Z., Shao, Z.M., Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival (2009) Clinical Cancer Research, 15 (9), pp. 2962-2970
Fievez, V., Szpakowska, M., Mosbah, A., Arumugam, K., Mathu, J., Counson, M., Development of Mimokines, chemokine N terminus-based CXCR4 inhibitors optimized by phage display and rational design (2018) Journal of Leukocyte Biology, 104 (2), pp. 343-357
Fra, A.M., Locati, M., Otero, K., Sironi, M., Signorelli, P., Massardi, M.L., Cutting edge: Scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6 (2003) Journal of Immunology, 170 (5), pp. 2279-2282
Freitas, C., Desnoyer, A., Meuris, F., Bachelerie, F., Balabanian, K., Machelon, V., The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers (2014) Cytokine & Growth Factor Reviews, 25 (3), pp. 307-316
Fukuma, N., Akimitsu, N., Hamamoto, H., Kusuhara, H., Sugiyama, Y., Sekimizu, K., A role of the Duffy antigen for the maintenance of plasma chemokine concentrations (2003) Biochemical and Biophysical Research Communications, 303 (1), pp. 137-139
Galliera, E., Jala, V.R., Trent, J.O., Bonecchi, R., Signorelli, P., Lefkowitz, R.J., beta-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6 (2004) The Journal of Biological Chemistry, 279 (24), pp. 25590-25597
Gardner, L., Patterson, A.M., Ashton, B.A., Stone, M.A., Middleton, J., The human Duffy antigen binds selected inflammatory but not homeostatic chemokines (2004) Biochemical and Biophysical Research Communications, 321 (2), pp. 306-312
Goguet-Surmenian, E., Richard-Fiardo, P., Guillemot, E., Benchetrit, M., Gomez-Brouchet, A., Buzzo, P., CXCR7-mediated progression of osteosarcoma in the lungs (2013) British Journal of Cancer, 109 (6), pp. 1579-1585
Goltsev, Y., Samusik, N., Kennedy-Darling, J., Bhate, S., Hale, M., Vazquez, G., deep profiling of mouse splenic architecture with CODEX multiplexed imaging (2018) Cell, 174 (4), pp. 968-981. , e915
Gosling, J., Dairaghi, D.J., Wang, Y., Hanley, M., Talbot, D., Miao, Z., Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK (2000) Journal of Immunology, 164 (6), pp. 2851-2856
Graham, G.J., Locati, M., Mantovani, A., Rot, A., Thelen, M., The biochemistry and biology of the atypical chemokine receptors (2012) Immunology Letters, 145 (1-2), pp. 30-38
Gravel, S., Malouf, C., Boulais, P.E., Berchiche, Y.A., Oishi, S., Fujii, N., The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: Roles of receptor domains (2010) The Journal of Biological Chemistry, 285 (49), pp. 37939-37943
Guillemot, E., Karimdjee-Soilihi, B., Pradelli, E., Benchetrit, M., Goguet-Surmenian, E., Millet, M.A., CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver (2012) British Journal of Cancer, 107 (12), pp. 1944-1949
Gustavsson, M., Wang, L., van Gils, N., Stephens, B.S., Zhang, P., Schall, T.J., Structural basis of ligand interaction with atypical chemokine receptor 3 (2017) Nature Communications, 8
Hansell, C.A.H., Fraser, A.R., Hayes, A.J., Pingen, M., Burt, C.L., Lee, K.M., The atypical chemokine receptor Ackr2 constrains NK cell migratory activity and promotes metastasis (2018) Journal of Immunology, 201 (8), pp. 2510-2519
Hansell, C.A., Schiering, C., Kinstrie, R., Ford, L., Bordon, Y., McInnes, I.B., Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice (2011) Blood, 117 (20), pp. 5413-5424
Hao, M., Weng, X., Wang, Y., Sun, X., Yan, T., Li, Y., Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy (2018) Biochemical Pharmacology, 147, pp. 128-140
Harata-Lee, Y., Turvey, M.E., Brazzatti, J.A., Gregor, C.E., Brown, M.P., Smyth, M.J., The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT (2014) Immunology and Cell Biology, 92 (10), pp. 815-824
Hartmann, T.N., Grabovsky, V., Pasvolsky, R., Shulman, Z., Buss, E.C., Spiegel, A., A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34 + cells (2008) Journal of Leukocyte Biology, 84 (4), pp. 1130-1140
Hassan, S., Ferrario, C., Saragovi, U., Quenneville, L., Gaboury, L., Baccarelli, A., The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer (2009) The American Journal of Pathology, 175 (1), pp. 66-73
Heinzel, K., Benz, C., Bleul, C.C., A silent chemokine receptor regulates steady-state leukocyte homing in vivo (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (20), pp. 8421-8426
Hernandez, L., Magalhaes, M.A., Coniglio, S.J., Condeelis, J.S., Segall, J.E., Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis (2011) Breast Cancer Research, 13 (6)
Horton, L.W., Yu, Y., Zaja-Milatovic, S., Strieter, R.M., Richmond, A., Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth (2007) Cancer Research, 67 (20), pp. 9791-9799
Horuk, R., Chitnis, C.E., Darbonne, W.C., Colby, T.J., Rybicki, A., Hadley, T.J., A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor (1993) Science, 261 (5125), pp. 1182-1184
Hou, T., Liang, D., Xu, L., Huang, X., Huang, Y., Zhang, Y., Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer (2013) Gynecologic Oncology, 130 (1), pp. 181-187
Humpert, M.L., Tzouros, M., Thelen, S., Bignon, A., Levoye, A., Arenzana-Seisdedos, F., Complementary methods provide evidence for the expression of CXCR7 on human B cells (2012) Proteomics, 12 (12), pp. 1938-1948
Ierano, C., Santagata, S., Napolitano, M., Guardia, F., Grimaldi, A., Antignani, E., CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells (2014) Cell Death & Disease, 5, p. e1310
Ikeda, Y., Kumagai, H., Skach, A., Sato, M., Yanagisawa, M., Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior (2013) Cell, 155 (6), pp. 1323-1336
Jamieson, T., Cook, D.N., Nibbs, R.J., Rot, A., Nixon, C., McLean, P., The chemokine receptor D6 limits the inflammatory response in vivo (2005) Nature Immunology, 6 (4), pp. 403-411
Juarez, J., Bradstock, K.F., Gottlieb, D.J., Bendall, L.J., Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro (2003) Leukemia, 17 (7), pp. 1294-1300
Kalatskaya, I., Berchiche, Y.A., Gravel, S., Limberg, B.J., Rosenbaum, J.S., Heveker, N., AMD3100 is a CXCR7 ligand with allosteric agonist properties (2009) Molecular Pharmacology, 75 (5), pp. 1240-1247
Keeley, E.C., Mehrad, B., Strieter, R.M., CXC chemokines in cancer angiogenesis and metastases (2010) Advances in Cancer Research, 106, pp. 91-111
Khanna, P., Chung, C.Y., Neves, R.I., Robertson, G.P., Dong, C., CD82/KAI expression prevents IL-8-mediated endothelial gap formation in late-stage melanomas (2014) Oncogene, 33 (22), pp. 2898-2908
Kin, N.W., Crawford, D.M., Liu, J., Behrens, T.W., Kearney, J.F., DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae (2008) Journal of Immunology, 180 (10), pp. 6663-6674
Klein, K.R., Karpinich, N.O., Espenschied, S.T., Willcockson, H.H., Dunworth, W.P., Hoopes, S.L., Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development (2014) Developmental Cell, 30 (5), pp. 528-540
Kleist, A.B., Getschman, A.E., Ziarek, J.J., Nevins, A.M., Gauthier, P.A., Chevigne, A., New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model (2016) Biochemical Pharmacology, 114, pp. 53-68
Lacalle, R.A., Blanco, R., Carmona-Rodriguez, L., Martin-Leal, A., Mira, E., Manes, S., Chemokine receptor signaling and the hallmarks of cancer (2017) International Review of Cell and Molecular Biology, 331, pp. 181-244
Latini, F.R., Bastos, A.U., Arnoni, C.P., Muniz, J.G., Person, R.M., Baleotti, W., Jr., DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer (2013) Blood Cells, Molecules & Diseases, 50 (3), pp. 161-165
Lazennec, G., Richmond, A., Chemokines and chemokine receptors: New insights into cancer-related inflammation (2010) Trends in Molecular Medicine, 16 (3), pp. 133-144
Lee, J.S., Frevert, C.W., Wurfel, M.M., Peiper, S.C., Wong, V.A., Ballman, K.K., Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo (2003) Journal of Immunology, 170 (10), pp. 5244-5251
Lee, K.M., McKimmie, C.S., Gilchrist, D.S., Pallas, K.J., Nibbs, R.J., Garside, P., D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion (2011) Blood, 118 (23), pp. 6220-6229
Lee, K.M., Wilson, G.J., Pingen, M., Fukuoka, A., Hansell, C.A.H., Bartolini, R., Placental chemokine compartmentalisation: A novel mammalian molecular control mechanism (2019) PLoS Biology, 17 (5)
Lee, J.S., Wurfel, M.M., Matute-Bello, G., Frevert, C.W., Rosengart, M.R., Ranganathan, M., The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation (2006) Journal of Immunology, 177 (11), pp. 8086-8094
Leick, M., Catusse, J., Follo, M., Nibbs, R.J., Hartmann, T.N., Veelken, H., CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B (2010) Immunology, 129 (4), pp. 536-546
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., Lagane, B., CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling (2009) Blood, 113 (24), pp. 6085-6093
Li, S., Fong, K.W., Gritsina, G., Zhang, A., Zhao, J.C., Kim, J., Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (2019) Cancer Research, 79 (10), pp. 2580-2592
Li, J.T., Jia, L.T., Liu, N.N., Zhu, X.S., Liu, Q.Q., Wang, X.L., MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7 (2015) Oncotarget, 6 (31), pp. 30818-30830
Li, D.D., Yang, C., Shao, Z.M., Yu, K.D., Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer (2018) Cancer Medicine, 7 (11), pp. 5497-5504
Lin, Z., Li, W., Zhang, H., Wu, W., Peng, Y., Zeng, Y., CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-kappaB signaling pathway in hepatocellular carcinoma (2016) Tumour Biology, 37 (3), pp. 3461-3468
Liu, Y., Zheng, H., Li, Q., Li, S., Lai, H., Song, E., Discovery of CCL18 antagonist blocking breast cancer metastasis (2019) Clinical & Experimental Metastasis, 36 (3), pp. 243-255
Luker, K.E., Lewin, S.A., Mihalko, L.A., Schmidt, B.T., Winkler, J.S., Coggins, N.L., Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells (2012) Oncogene, 31 (45), pp. 4750-4758
Luker, K.E., Steele, J.M., Mihalko, L.A., Ray, P., Luker, G.D., Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands (2010) Oncogene, 29 (32), pp. 4599-4610
Luo, Y., Azad, A.K., Karanika, S., Basourakos, S.P., Zuo, X., Wang, J., Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models (2018) International Journal of Cancer, 142 (10), pp. 2163-2174
Maeda, S., Kuboki, S., Nojima, H., Shimizu, H., Yoshitomi, H., Furukawa, K., Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma (2017) Cytokine, 95, pp. 12-21
Maishi, N., Ohga, N., Hida, Y., Akiyama, K., Kitayama, K., Osawa, T., CXCR7: A novel tumor endothelial marker in renal cell carcinoma (2012) Pathology International, 62 (5), pp. 309-317
Martinez de la Torre, Y., Buracchi, C., Borroni, E.M., Dupor, J., Bonecchi, R., Nebuloni, M., Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (7), pp. 2319-2324
Martinez de la Torre, Y., Locati, M., Buracchi, C., Dupor, J., Cook, D.N., Bonecchi, R., Increased inflammation in mice deficient for the chemokine decoy receptor D6 (2005) European Journal of Immunology, 35 (5), pp. 1342-1346
Massara, M., Bonavita, O., Mantovani, A., Locati, M., Bonecchi, R., Atypical chemokine receptors in cancer: Friends or foes? (2016) Journal of Leukocyte Biology, 99 (6), pp. 927-933
Massara, M., Bonavita, O., Savino, B., Caronni, N., Mollica Poeta, V., Sironi, M., ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity (2018) Nature Communications, 9 (1)
Maussang, D., Mujic-Delic, A., Descamps, F.J., Stortelers, C., Vanlandschoot, P., Stigter-van Walsum, M., Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo (2013) The Journal of Biological Chemistry, 288 (41), pp. 29562-29572
Mayr, F.B., Spiel, A.O., Leitner, J.M., Firbas, C., Kliegel, T., Jilma-Stohlawetz, P., Duffy antigen modifies the chemokine response in human endotoxemia (2008) Critical Care Medicine, 36 (1), pp. 159-165
McKimmie, C.S., Fraser, A.R., Hansell, C., Gutierrez, L., Philipsen, S., Connell, L., Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1 (2008) Journal of Immunology, 181 (11), pp. 8171-8181
Miao, Z., Luker, K.E., Summers, B.C., Berahovich, R., Bhojani, M.S., Rehemtulla, A., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (40), pp. 15735-15740
Miller, L.H., Mason, S.J., Clyde, D.F., McGinniss, M.H., The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy (1976) The New England Journal of Medicine, 295 (6), pp. 302-304
Nalls, M.A., Wilson, J.G., Patterson, N.J., Tandon, A., Zmuda, J.M., Huntsman, S., Admixture mapping of white cell count: Genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies (2008) American Journal of Human Genetics, 82 (1), pp. 81-87
Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.G., CXCR7 functions as a scavenger for CXCL12 and CXCL11 (2010) PLoS One, 5 (2)
Neote, K., Mak, J.Y., Kolakowski, L.F.J., Schall, T.J., Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor (1994) Blood, 84 (1), pp. 44-52
Nibbs, R.J., Graham, G.J., Immune regulation by atypical chemokine receptors (2013) Nature Reviews. Immunology, 13 (11), pp. 815-829
Nibbs, R.J., Kriehuber, E., Ponath, P.D., Parent, D., Qin, S., Campbell, J.D., The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors (2001) The American Journal of Pathology, 158 (3), pp. 867-877
Nibbs, R.J., Wylie, S.M., Pragnell, I.B., Graham, G.J., Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5 (1997) The Journal of Biological Chemistry, 272 (19), pp. 12495-12504
Nibbs, R.J., Wylie, S.M., Yang, J., Landau, N.R., Graham, G.J., Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6 (1997) The Journal of Biological Chemistry, 272 (51), pp. 32078-32083
Nomiyama, H., Osada, N., Yoshie, O., A family tree of vertebrate chemokine receptors for a unified nomenclature (2011) Developmental and Comparative Immunology, 35 (7), pp. 705-715
Odemis, V., Lipfert, J., Kraft, R., Hajek, P., Abraham, G., Hattermann, K., The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells (2012) Glia, 60 (3), pp. 372-381
Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion (2005) Cell, 121 (3), pp. 335-348
Pacifico, F., Lepore, A., Mellone, S., Sanguigno, L., Federico, G., Greco, A., The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer (2017) Genes & Cancer, 8 (5-6), pp. 577-588
Peiper, S.C., Wang, Z.X., Neote, K., Martin, A.W., Showell, H.J., Conklyn, M.J., The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor (1995) The Journal of Experimental Medicine, 181 (4), pp. 1311-1317
Pruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J., The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity (2009) Nature Immunology, 10 (1), pp. 101-108
Puddinu, V., Casella, S., Radice, E., Thelen, S., Dirnhofer, S., Bertoni, F., ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration (2017) Oncotarget, 8 (49), pp. 85068-85084
Qiao, Y., Zhang, C., Li, A., Wang, D., Luo, Z., Ping, Y., IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma (2018) Oncogene, 37 (7), pp. 873-883
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C.M., Gerard, N.P., Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 (2010) Proceedings of the National Academy of Sciences of the United States of America, 107 (2), pp. 628-632
Regard, J.B., Sato, I.T., Coughlin, S.R., Anatomical profiling of G protein-coupled receptor expression (2008) Cell, 135 (3), pp. 561-571
Reich, D., Nalls, M.A., Kao, W.H., Akylbekova, E.L., Tandon, A., Patterson, N., Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene (2009) PLoS Genetics, 5 (1)
Rot, A., McKimmie, C., Burt, C.L., Pallas, K.J., Jamieson, T., Pruenster, M., Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor (2013) Journal of Immunology, 190 (12), pp. 6450-6456
Salazar, N., Carlson, J.C., Huang, K., Zheng, Y., Oderup, C., Gross, J., A chimeric antibody against ACKR3/CXCR7 in combination with TMZ activates immune responses and extends survival in mouse GBM models (2018) Molecular Therapy, 26 (5), pp. 1354-1365
Salazar, N., Munoz, D., Kallifatidis, G., Singh, R.K., Jorda, M., Lokeshwar, B.L., The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation (2014) Molecular Cancer, 13, p. 198
Sanchez-Alcaniz, J.A., Haege, S., Mueller, W., Pla, R., Mackay, F., Schulz, S., Cxcr7 controls neuronal migration by regulating chemokine responsiveness (2011) Neuron, 69 (1), pp. 77-90
Sanchez-Martin, L., Sanchez-Mateos, P., Cabanas, C., CXCR7 impact on CXCL12 biology and disease (2013) Trends in Molecular Medicine, 19 (1), pp. 12-22
Savas, P., Virassamy, B., Ye, C., Salim, A., Mintoff, C.P., Caramia, F., Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis (2018) Nature Medicine, 24 (7), pp. 986-993
Savino, B., Caronni, N., Anselmo, A., Pasqualini, F., Borroni, E.M., Basso, G., ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma (2014) Cancer Immunology Research, 2 (7), pp. 679-689
Schnabel, R.B., Baumert, J., Barbalic, M., Dupuis, J., Ellinor, P.T., Durda, P., Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators (2010) Blood, 115 (26), pp. 5289-5299
Schols, D., Este, J.A., Henson, G., De Clercq, E., Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4 (1997) Antiviral Research, 35 (3), pp. 147-156
Schrevel, M., Karim, R., ter Haar, N.T., van der Burg, S.H., Trimbos, J.B., Fleuren, G.J., CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients (2012) British Journal of Cancer, 106 (9), pp. 1520-1525
Shams, K., Kurowska-Stolarska, M., Schutte, F., Burden, A.D., McKimmie, C.S., Graham, G.J., MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2 (2018) The Journal of Biological Chemistry, 293 (8), pp. 3003-3012
Shen, H., Schuster, R., Stringer, K.F., Waltz, S.E., Lentsch, A.B., The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth (2006) The FASEB Journal, 20 (1), pp. 59-64
Shi, J.Y., Yang, L.X., Wang, Z.C., Wang, L.Y., Zhou, J., Wang, X.Y., CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma (2015) The Journal of Pathology, 235 (4), pp. 546-558
Shin, W.J., Zabel, B.A., Pachynski, R.K., Mechanisms and functions of chemerin in cancer: Potential roles in therapeutic intervention (2018) Frontiers in Immunology, 9, p. 2772
Sierro, F., Biben, C., Martinez-Munoz, L., Mellado, M., Ransohoff, R.M., Li, M., Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (37), pp. 14759-14764
Sjoberg, E., Meyrath, M., Milde, L., Herrera, M., Lovrot, J., Hagerstrand, D., A novel ACKR2-dependent role of fibroblast-derived CXCL14 in epithelial-to-mesenchymal transition and metastasis of breast cancer (2019) Clinical Cancer Research, 25 (12), pp. 3702-3717
Stacer, A.C., Fenner, J., Cavnar, S.P., Xiao, A., Zhao, S., Chang, S.L., Endothelial CXCR7 regulates breast cancer metastasis (2016) Oncogene, 35 (13), pp. 1716-1724
Su, A.I., Cooke, M.P., Ching, K.A., Hakak, Y., Walker, J.R., Wiltshire, T., Large-scale analysis of the human and mouse transcriptomes (2002) Proceedings of the National Academy of Sciences of the United States of America, 99 (7), pp. 4465-4470
Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression (2010) Cancer Metastasis Reviews, 29 (4), pp. 709-722
Sun, G., Wang, Y., Zhu, Y., Huang, C., Ji, Q., Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator (2011) Acta Oto-Laryngologica, 131 (2), pp. 197-203
Szabo, M.C., Soo, K.S., Zlotnik, A., Schall, T.J., Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor (1995) The Journal of Biological Chemistry, 270 (43), pp. 25348-25351
Szpakowska, M., Chevigne, A., vCCL2/vMIP-II, the viral master KEYmokine (2016) Journal of Leukocyte Biology, 99 (6), pp. 893-900
Szpakowska, M., Dupuis, N., Baragli, A., Counson, M., Hanson, J., Piette, J., Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7 (2016) Biochemical Pharmacology, 114, pp. 14-21
Szpakowska, M., Meyrath, M., Reynders, N., Counson, M., Hanson, J., Steyaert, J., Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists (2018) Biochemical Pharmacology, 153, pp. 299-309
Szpakowska, M., Nevins, A.M., Meyrath, M., Rhainds, D., D'Huys, T., Guite-Vinet, F., Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3 (2018) British Journal of Pharmacology, 175 (9), pp. 1419-1438
Thelen, M., Thelen, S., CXCR7, CXCR4 and CXCL12: An eccentric trio? (2008) Journal of Neuroimmunology, 198 (1-2), pp. 9-13
Thiriot, A., Perdomo, C., Cheng, G., Novitzky-Basso, I., McArdle, S., Kishimoto, J.K., Differential DARC/ACKR1 expression distinguishes venular from non-venular endothelial cells in murine tissues (2017) BMC Biology, 15 (1)
Townson, J.R., Nibbs, R.J., Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: Comparison to human CCX-CKR (2002) European Journal of Immunology, 32 (5), pp. 1230-1241
Ulvmar, M.H., Werth, K., Braun, A., Kelay, P., Hub, E., Eller, K., The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes (2014) Nature Immunology, 15 (7), pp. 623-630
Walenkamp, A.M.E., Lapa, C., Herrmann, K., Wester, H.J., CXCR4 ligands: The next big hit? (2017) Journal of Nuclear Medicine, 58, pp. 77S-82S
Wang, H., Beaty, N., Chen, S., Qi, C.F., Masiuk, M., Shin, D.M., The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12 (2012) Blood, 119 (2), pp. 465-468
Wang, Y., Li, G., Stanco, A., Long, J.E., Crawford, D., Potter, G.B., CXCR4 and CXCR7 have distinct functions in regulating interneuron migration (2011) Neuron, 69 (1), pp. 61-76
Wang, J., Ou, Z.L., Hou, Y.F., Luo, J.M., Shen, Z.Z., Ding, J., Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential (2006) Oncogene, 25 (54), pp. 7201-7211
Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K.J., The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (2008) The Journal of Biological Chemistry, 283 (7), pp. 4283-4294
Wani, N., Nasser, M.W., Ahirwar, D.K., Zhao, H., Miao, Z., Shilo, K., C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment (2014) Breast Cancer Research, 16 (3)
Weber, M., Blair, E., Simpson, C.V., O'Hara, M., Blackburn, P.E., Rot, A., The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines (2004) Molecular Biology of the Cell, 15 (5), pp. 2492-2508
Werner, T.A., Forster, C.M., Dizdar, L., Verde, P.E., Raba, K., Schott, M., CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma (2017) British Journal of Cancer, 117 (12), pp. 1837-1845
Wijtmans, M., Maussang, D., Sirci, F., Scholten, D.J., Canals, M., Mujic-Delic, A., Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists (2012) European Journal of Medicinal Chemistry, 51, pp. 184-192
Wu, F.Y., Ou, Z.L., Feng, L.Y., Luo, J.M., Wang, L.P., Shen, Z.Z., Chemokine decoy receptor d6 plays a negative role in human breast cancer (2008) Molecular Cancer Research, 6 (8), pp. 1276-1288
Wu, W., Qian, L., Chen, X., Ding, B., Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer (2015) International Journal of Clinical and Experimental Pathology, 8 (10), pp. 13217-13224
Wu, Y.C., Tang, S.J., Sun, G.H., Sun, K.H., CXCR7 mediates TGFbeta1-promoted EMT and tumor-initiating features in lung cancer (2016) Oncogene, 35 (16), pp. 2123-2132
Yamada, K., Maishi, N., Akiyama, K., Towfik Alam, M., Ohga, N., Kawamoto, T., CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property (2015) International Journal of Cancer, 137 (12), pp. 2825-2836
Yang, D., Dai, T., Xue, L., Liu, X., Wu, B., Geng, J., Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance (2015) International Journal of Clinical and Experimental Pathology, 8 (10), pp. 13051-13058
Yang, C., Yu, K.D., Xu, W.H., Chen, A.X., Fan, L., Ou, Z.L., Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer (2013) PLoS One, 8 (11)
Yu, S., Crawford, D., Tsuchihashi, T., Behrens, T.W., Srivastava, D., The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling (2011) Developmental Dynamics, 240 (2), pp. 384-393
Yu, P.F., Huang, Y., Xu, C.L., Lin, L.Y., Han, Y.Y., Sun, W.H., Downregulation of CXCL12 in mesenchymal stromal cells by TGFbeta promotes breast cancer metastasis (2017) Oncogene, 36 (6), pp. 840-849
Yu, K.D., Wang, X., Yang, C., Zeng, X.H., Shao, Z.M., Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse (2015) Oncotarget, 6 (28), pp. 26519-26527
Zabel, B.A., Wang, Y., Lewen, S., Berahovich, R.D., Penfold, M.E., Zhang, P., Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands (2009) Journal of Immunology, 183 (5), pp. 3204-3211
Zeng, X.H., Ou, Z.L., Yu, K.D., Feng, L.Y., Yin, W.J., Li, J., Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes (2011) Breast Cancer Research and Treatment, 125 (3), pp. 715-727
Zheng, N., Liu, W., Chen, J., Li, B., Liu, J., Wang, J., CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer (2019) Molecular Carcinogenesis, 58 (1), pp. 144-155
Zhou, S., Liu, M., Hu, Y., An, W., Liang, X., Yu, W., Expression of Duffy antigen receptor for chemokines (DARC) is down-regulated in colorectal cancer (2015) Journal of Receptor and Signal Transduction Research, 35 (5), pp. 462-467
Zhu, Q., Jiang, L., Wang, X., The expression of Duffy antigen receptor for chemokines by epithelial ovarian cancer decreases growth potential (2017) Oncology Letters, 13 (6), pp. 4302-4306
Zhu, Z., Sun, Z., Wang, Z., Guo, P., Zheng, X., Xu, H., Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer (2013) The Journal of Surgical Research, 183 (1), pp. 177-183
Zhu, Y., Tang, W., Liu, Y., Wang, G., Liang, Z., Cui, L., CCX-CKR expression in colorectal cancer and patient survival (2014) The International Journal of Biological Markers, 29 (1), pp. e40-e48
Zlotnik, A., Yoshie, O., Chemokines: A new classification system and their role in immunity (2000) Immunity, 12 (2), pp. 121-127
Zlotnik, A., Yoshie, O., The chemokine superfamily revisited (2012) Immunity, 36 (5), pp. 705-716
